Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mauro Schechter

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
Tropical Medicine & International Health : TM & IH|April 1, 2008
Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America, Olivia Keiser, Kathryn Anastos, et al.
AIDS Research and Human Retroviruses|October 9, 2010
Estimating the extent of underreporting of mortality among HIV-infected individuals in Rio de Janeiro, BrazilAntonio G Pacheco, Valeria Saraceni, Suely H Tuboi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 18, 2011
Cancer in HIV-infected persons from the Caribbean, Central and South AmericaValeria I Fink, Bryan E Shepherd, Carina Cesar, et al.
Journal of Women'S Health (2002)|February 5, 2008
Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaborationPaula Braitstein, Andrew Boulle, Denis Nash, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2016
Symptoms, Side Effects and Adherence in the iPrEx Open-Label ExtensionDavid V Glidden, K Rivet Amico, Albert Y Liu, et al.
AIDS Research and Human Retroviruses|May 24, 2019
Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration ProjectMatthew A Spinelli, David V Glidden, Peter L Anderson, et al.
Lancet (London, England)|March 15, 2006
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countriesPaula Braitstein, Martin W G Brinkhof, François Dabis, et al.
The Lancet. HIV|January 21, 2018
Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trialJean-Michel Molina, Birgit Grund, Fred Gordin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 26, 2009
Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settingsSuely Hiromi Tuboi, Antonio Guilherme Pacheco, Lee H Harrison, et al.
AIDS (London, England)|June 15, 2021
Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohortLuke A Granger, Isabella Huettner, Franka Debeljak, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Tropical Medicine & International Health : TM & IH|April 1, 2008
Antiretroviral therapy in resource-limited settings 1996 to 2006: patient characteristics, treatment regimens and monitoring in sub-Saharan Africa, Asia and Latin America, Olivia Keiser, Kathryn Anastos, et al.
AIDS Research and Human Retroviruses|October 9, 2010
Estimating the extent of underreporting of mortality among HIV-infected individuals in Rio de Janeiro, BrazilAntonio G Pacheco, Valeria Saraceni, Suely H Tuboi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 18, 2011
Cancer in HIV-infected persons from the Caribbean, Central and South AmericaValeria I Fink, Bryan E Shepherd, Carina Cesar, et al.
Journal of Women'S Health (2002)|February 5, 2008
Gender and the use of antiretroviral treatment in resource-constrained settings: findings from a multicenter collaborationPaula Braitstein, Andrew Boulle, Denis Nash, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2016
Symptoms, Side Effects and Adherence in the iPrEx Open-Label ExtensionDavid V Glidden, K Rivet Amico, Albert Y Liu, et al.
AIDS Research and Human Retroviruses|May 24, 2019
Impact of Estimated Pre-Exposure Prophylaxis (PrEP) Adherence Patterns on Bone Mineral Density in a Large PrEP Demonstration ProjectMatthew A Spinelli, David V Glidden, Peter L Anderson, et al.
Lancet (London, England)|March 15, 2006
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countriesPaula Braitstein, Martin W G Brinkhof, François Dabis, et al.
The Lancet. HIV|January 21, 2018
Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trialJean-Michel Molina, Birgit Grund, Fred Gordin, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 26, 2009
Mortality associated with discordant responses to antiretroviral therapy in resource-constrained settingsSuely Hiromi Tuboi, Antonio Guilherme Pacheco, Lee H Harrison, et al.
AIDS (London, England)|June 15, 2021
Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohortLuke A Granger, Isabella Huettner, Franka Debeljak, et al.
Pageof 12